|
|
|
|
| LEADER |
03341nmm a2200301 u 4500 |
| 001 |
EB000629174 |
| 003 |
EBX01000000000000000482256 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9781468452549
|
| 100 |
1 |
|
|a Shaw, Brian F.
|
| 245 |
0 |
0 |
|a Anxiety Disorders
|h Elektronische Ressource
|b Psychological and Biological Perspectives
|c by Brian F. Shaw
|
| 250 |
|
|
|a 1st ed. 1986
|
| 260 |
|
|
|a New York, NY
|b Springer US
|c 1986, 1986
|
| 300 |
|
|
|a XVI, 252 p
|b online resource
|
| 505 |
0 |
|
|a Section I: Classification and Nosology -- Proposed Revisions in the DSM-III Classification of Anxiety Disorders Based on Research and Clinical Experience -- The Differentiation of Anxiety and Depressive Syndromes -- Section 2: Basic Science Studies of Anxiety -- The Neurobiology of Anxiety: A Tale of Two Systems -- The Psychophysiology of Anxiety and Hedonic Affect: Motivational Specificity -- Anxiety and Memory -- Section 3: Psychological Treatment -- A Psychological Model of Panic -- Cognitive Approaches to Anxiety Disorders -- Exposure-Based Treatments for Anxiety Disorders -- Psychosocial Treatment of Anxiety Disorders -- Self-Control Skills for the Treatment of Anxiety Disorders -- Section 4: Pharmacological Treatment -- New Perspectives on the Treatment of Panic and Phobic Disorders -- The Use of Benzodiazepines in Anxiety Disorders -- New Approaches to the Pharmacological Treatment of Anxiety and Depression -- Section 5: Summary -- Anxiety Disorders: Future Directions and Closing Comments -- Contributors
|
| 653 |
|
|
|a Clinical psychology
|
| 653 |
|
|
|a Clinical Psychology
|
| 653 |
|
|
|a Psychobiology
|
| 653 |
|
|
|a Human behavior
|
| 653 |
|
|
|a Behavioral Neuroscience
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 028 |
5 |
0 |
|a 10.1007/978-1-4684-5254-9
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4684-5254-9?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 612.8
|
| 520 |
|
|
|a Anxiety is one of those entltles which everyone "knows", but which ultimately resists simple objective description. The essence of the phenomenon is its subjectivity. True it has its well documented associated physiological events: the increased pulse rate and blood pressure, sweating, and so on, but each of these phenomena may also be part of physical exertion, fear, or even pleasurable excitement. They cannot fully define the sense of threat, danger, collapse, malignancy in greater or smaller amount, in greater or lesser locali sation, with more or less objective evidence for its validity that characterises the particular psychological pain we all recognize as anxiety. It is precisely the essential subjectivity of anxiety and its association with an enormous range of experience that makes it difficult to assign to it well-defined diagnostic labels of the kinds so carefully described by Dr. Spitzer in his chapter on classification. His chapter ranges from the extreme dread of "Panic Disorders", to the diffuse terror of the environment which used to be labelled "Agoraphobia" (and is still so called in the day to day pragmatic usage of many clinics) and is not assimilated to the class of phobias with the label "Social Phobias". He also addresses the "Simple Phobias" which are perhaps the most readily labelled of the many varieties of anxiety
|